Profile data is unavailable for this security.
About the company
Delta-Fly Pharma, Inc. is a Japan-based company principally engaged in the research, development, manufacture and sale of pharmaceuticals. The Company's development pipeline includes anticancer drug candidate compound DFP-10917 whose target disease is refractory or recurrent acute myelogenous leukemia, anticancer drug candidate compound DFP-14323 whose target disease is lung cancer, anti-cancer drug candidate compound DFP-11207 whose target disease is solid cancer, anticancer drug candidate compound DFP-14927 whose target disease is solid cancer or blood cancer, anticancer drug candidate compound DFP-10825 whose target disease is peritoneal dissemination metastatic cancer.
- Revenue in JPY (TTM)0.00
- Net income in JPY-1.26bn
- Incorporated2010
- Employees11.00
- LocationDelta-Fly Pharma Inc37-5, Nishikino, Miyajima, Kawauchi-choTOKUSHIMA-SHI 771-0116JapanJPN
- Phone+81 362311278
- Websitehttps://www.delta-flypharma.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OncoTherapy Science, Inc. | 610.12m | -1.29bn | 3.35bn | 60.00 | -- | 9.23 | -- | 5.50 | -6.09 | -6.09 | 2.87 | 1.62 | 0.513 | 9.08 | 7.69 | -- | -108.31 | -55.67 | -182.73 | -63.82 | -29.13 | -1.49 | -211.13 | -247.47 | 2.07 | -189.93 | 0.232 | -- | -46.24 | 16.81 | -15.15 | -- | -48.33 | -- |
| D.Western Therapeutics Institute Inc | 443.18m | -1.04bn | 3.55bn | 21.00 | -- | 3.69 | -- | 8.01 | -32.29 | -32.29 | 13.84 | 29.84 | 0.1784 | 0.472 | 3.10 | 21,103,950.00 | -42.16 | -13.06 | -45.11 | -14.36 | 91.32 | 94.29 | -236.36 | -72.51 | 11.65 | -- | 0.509 | -- | -4.40 | 7.90 | -89.07 | -- | 7.08 | -- |
| Kringle Pharma Inc | 77.93m | -904.81m | 3.77bn | 13.00 | -- | 1.61 | -- | 48.41 | -159.92 | -159.92 | 13.58 | 356.64 | 0.027 | -- | 2.80 | 5,994,308.00 | -31.29 | -19.00 | -33.20 | -20.23 | -- | -- | -1,161.12 | -156.51 | 12.85 | -- | -- | -- | -82.33 | -- | -157.41 | -- | -- | -- |
| Kubota Pharmaceutical Holdings Co Ltd | 39.74m | -1.39bn | 3.83bn | 12.00 | -- | 1.64 | -- | 96.32 | -24.82 | -24.82 | 0.711 | 41.58 | 0.0118 | 0.3815 | 26.89 | 3,312,000.00 | -41.32 | -36.51 | -45.53 | -39.47 | 72.88 | -- | -3,492.38 | -13,528.87 | 8.97 | -- | 0.0555 | -- | 383.24 | -- | 26.11 | -- | 24.38 | -- |
| Perseus Proteomics Inc | 96.22m | -1.12bn | 3.83bn | 24.00 | -- | 2.37 | -- | 39.84 | -95.57 | -95.57 | 8.18 | 131.49 | 0.0424 | 1.82 | 11.22 | 4,009,083.00 | -49.52 | -33.51 | -51.65 | -34.95 | 89.01 | 93.09 | -1,168.66 | -470.63 | 17.58 | -- | 0.00 | -- | 30.96 | -20.89 | -31.38 | -- | 228.18 | -- |
| Human Metabolome Technologies Inc | 1.32bn | 282.64m | 3.90bn | 57.00 | 13.80 | 2.21 | 10.70 | 2.95 | 47.83 | 47.83 | 223.67 | 299.17 | 0.6302 | 14.23 | 4.74 | 23,186,330.00 | 13.48 | -- | 16.73 | -- | 65.03 | -- | 21.39 | -- | 4.27 | 151.90 | 0.1103 | -- | 6.21 | -- | 6.71 | -- | -- | -- |
| FunPep Co Ltd | 530.00k | -933.42m | 4.14bn | 15.00 | -- | 1.67 | -- | 7,802.64 | -40.11 | -40.11 | 0.0225 | 94.97 | 0.0002 | -- | -- | 35,333.33 | -34.04 | -27.10 | -35.68 | -28.75 | -- | -- | -176,116.20 | -815.82 | 25.95 | -1,765.73 | 0.00 | -- | -50.33 | -72.80 | 20.39 | -- | -13.14 | -- |
| BrightPath Biotherapeutics Co Ltd | 72.00k | -1.17bn | 4.19bn | 32.00 | -- | 4.26 | -- | 58,132.45 | -18.30 | -18.30 | 0.0011 | 13.84 | 0.00005 | -- | 2.36 | -- | -79.69 | -51.56 | -87.69 | -54.32 | 75.00 | 68.63 | -1,622,336.00 | -22,321.82 | -- | -435.39 | 0.1031 | -- | -98.64 | -78.47 | 21.37 | -- | -46.55 | -- |
| Renascience Inc | 194.17m | -258.34m | 4.59bn | 3.00 | -- | 2.86 | -- | 23.63 | -20.32 | -20.32 | 15.27 | 126.40 | 0.089 | -- | -- | -- | -11.84 | -- | -12.49 | -- | 85.31 | -- | -133.05 | -- | -- | -- | 0.1814 | -- | 93.11 | -- | 23.07 | -- | -- | -- |
| Immuno-Biological Laboratories Co., Ltd. | 788.12m | -192.71m | 4.63bn | 60.00 | -- | 4.21 | -- | 5.87 | -20.69 | -20.69 | 84.62 | 118.02 | 0.5144 | 0.8788 | 3.78 | 13,135,280.00 | -12.58 | -15.11 | -14.85 | -17.61 | 62.06 | 56.66 | -24.45 | -50.04 | 3.49 | 0.494 | 0.1774 | -- | 22.71 | 0.9405 | -11.97 | -- | -- | -- |
| Delta-Fly Pharma Inc | 0.00 | -1.26bn | 4.65bn | 11.00 | -- | 2.75 | -- | -- | -187.93 | -187.93 | 0.00 | 205.25 | 0.00 | -- | -- | 0.00 | -92.45 | -53.35 | -103.56 | -55.60 | -- | -- | -- | -769.75 | -- | -391.17 | 0.00 | -- | -100.00 | -- | -37.37 | -- | -- | -- |
| KAINOS Laboratories, Inc. | 5.06bn | 637.97m | 5.21bn | 144.00 | 7.50 | 0.769 | 6.89 | 1.03 | 152.41 | 152.41 | 1,206.78 | 1,486.43 | 0.6053 | 3.08 | 4.55 | -- | 7.64 | 6.92 | 9.96 | 9.26 | 50.46 | 51.84 | 12.62 | 10.80 | 2.43 | -- | 0.1221 | 18.46 | 2.71 | 1.60 | 12.28 | 10.57 | -9.83 | 16.36 |
| Solasia Pharma KK | 617.00m | -1.11bn | 5.22bn | 24.00 | -- | 2.50 | -- | 8.47 | -6.61 | -6.61 | 3.67 | 10.78 | 0.2301 | 4.10 | 1.93 | 25,708,330.00 | -41.51 | -48.57 | -47.74 | -58.83 | 54.78 | 71.01 | -180.39 | -300.89 | 2.91 | -- | 0.031 | -- | -43.50 | 14.18 | 56.36 | -- | -- | -- |
| Kidswell Bio Corp | 2.43bn | -1.42bn | 5.24bn | 41.00 | -- | 6.23 | -- | 2.15 | -40.81 | -40.81 | 68.79 | 21.35 | 0.5415 | 1.84 | 2.47 | -- | -31.67 | -57.41 | -51.25 | -81.13 | 42.75 | 55.20 | -58.49 | -123.52 | 1.70 | -28.91 | 0.7559 | -- | -12.43 | 18.93 | -116.31 | -- | -- | -- |
| MEDRx Co Ltd | 22.57m | -770.66m | 5.71bn | 22.00 | -- | 2.78 | -- | 253.05 | -20.97 | -20.97 | 0.6128 | 47.84 | 0.0143 | 0.00 | 4.22 | 1,025,955.00 | -48.80 | -58.15 | -50.27 | -62.23 | 100.00 | 95.70 | -3,414.38 | -1,526.17 | 43.57 | -- | 0.00 | -- | -50.35 | 28.60 | 16.04 | -- | -55.29 | -- |
| Cyfuse Biomedical KK | 64.79m | -645.40m | 5.74bn | 21.00 | -- | 1.87 | -- | 88.55 | -82.27 | -82.27 | 8.26 | 378.39 | 0.0153 | 0.5202 | 13.80 | 3,085,095.00 | -15.19 | -- | -17.68 | -- | 61.81 | -- | -996.19 | -- | 6.39 | -81.61 | 0.2126 | -- | -83.68 | -- | -24.32 | -- | -- | -- |
Data as of May 17 2024. Currency figures normalised to Delta-Fly Pharma Inc's reporting currency: Japanese Yen JPY
